Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Ixempra (Ixapebilone) – New Cancer Therapy



Microtubule inhibitor that stops cells separating during the G2 phase

Ixabepilone is a microtubule inhibitor that stops cells separating during the G2 phase of the cell cycling.

  • Structure of the breast and mammary gland
    Structure of the breast and mammary gland.
  • The most common cancers diagnosed in women in the UK
    The most common cancers diagnosed in women in the UK in 2001 out of a total...
  • Tumour cells spread from the primary site
    The mechanism by which tumour cells spread from the primary site via blood...
  • advanced breast cancer sites
    Diagram showing the most likely sites for local and distant spread of...
  • Tumour cells develop resistance to chemotherapeutic agents
    An illustration of how tumour cells develop resistance to chemotherapeutic...
  • Microtubule inhibitor that stops cells separating during the G2 phase
    Ixabepilone is a microtubule inhibitor that stops cells separating during the...

Back to Project Details



Related Projects

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Avastin (bevacizumab) - Angiogenesis
The product of a joint development programme between Genentech and...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.